Strata Critical Medical, Inc. (SRTA)

NASDAQ: SRTA · Real-Time Price · USD

6.03

+0.09 (1.52%)

At close: Aug 11, 2026, 4:00 PM EDT

6.10

+0.07 (1.16%)

After-hours: Aug 11, 2026, 5:07 PM EDT

Strata Critical Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	40.22	41.35	-27.31	-56.08	-27.26	-36.92
Depreciation & Amortization	16.29	8.19	5.96	7.11	5.73	1.17
Stock-Based Compensation	17.01	17.83	19.89	12.5	8.28	11.28
Other Adjustments	-57.18	-107.2	1.94	10.85	-23.86	5.4
Change in Receivables	-5.77	-12.03	-1	-10.25	-5.35	-1.74
Changes in Accounts Payable	-1.18	2.38	-8.34	9.05	9.9	2.52
Changes in Unearned Revenue	-0.62	1.68	-0.12	0.12	0.74	1.56
Changes in Other Operating Activities	0.53	-1.11	6.45	-5.65	-5.31	-4.9
Operating Cash Flow	-36.03	-48.91	-2.52	-32.35	-37.13	-21.63
Operating Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-12.42	-9.6	-30.86	-	-0.73	-0.49
Sale of Property, Plant & Equipment	-	-	-	0.14	-	-
Purchases of Intangible Assets	-1.07	-1.42	-2.12	-0.04	-	-12.36
Purchases of Investments	-56.11	-146.26	-143.26	-265.97	-228.02	-308.77
Proceeds from Sale of Investments	105.4	296.36	177.45	285.07	356.38	28.51
Cash Acquisitions	-101.36	-66.54	-2.23	-	-48.1	-23.07
Proceeds from Business Divestments	-3.1	-2.81	-	-	-	-
Other Investing Activities	-	-	-	-2.11	-0.19	-
Investing Cash Flow	1.51	69.75	-1.02	17.09	79.34	-316.17

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Repaid	-	-	-	-	-	-1.17
Net Long-Term Debt Issued (Repaid)	-	-	-	-	-	-1.17
Issuance of Common Stock	0.17	0.19	0.17	0.07	0.09	335.04
Repurchase of Common Stock	-8.44	-9.11	-5.93	-0.15	-1.17	-3.17
Net Common Stock Issued (Repurchased)	-8.26	-8.91	-5.76	-0.08	-1.08	331.87
Financing Cash Flow	-8.6	-8.91	-5.76	-0.08	-1.08	330.7

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.62	-0.34	-0.08	-0.07	0.07	-0.01
Net Cash Flow	-43.74	11.59	-9.37	-15.4	41.2	-7.11

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-48.45	-58.51	-33.38	-32.35	-37.86	-22.12
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-18.93%	-29.68%	-22.74%	-14.37%	-25.91%	-32.93%
Free Cash Flow Per Share	-0.56	-0.71	-0.43	-0.44	-0.53	-0.28
Levered Free Cash Flow	-7.92	42.89	-54.22	-45.45	-16.94	-38.22
Unlevered Free Cash Flow	-17.81	-20.81	-49.44	-55.75	-41.73	-29.42

SEC Filings: 10-K · 10-Q